MetaCap

Scinai Immunotherapeutics Insider Trades

NASDAQ: SCNIHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.58+0.0258 (+1.66%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Scinai Immunotherapeutics insider activity

Over the last 12 months, Scinai Immunotherapeutics insiders reported 2 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows GERMAIN MARK (Director) reporting a transaction in 120,000,000 shares on Jun 16, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put SCNI's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

SCNI insider transactions

Scinai Immunotherapeutics insider transactions
DateInsiderTypeSharesValueFiling
Jun 16, 2026Reichman AmirChief Executive OfficerAward400,000,000—Form 4
Jun 16, 2026GERMAIN MARKDirectorAward120,000,000—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related